Anju Vyas

Hospital Pharmacist with nearly 30 years of diverse clinical and leadership experience across the General Medicine, Medical Oncology, Palliative and Complex Malignant Hematology Settings. Proven track record in advancing high-quality patient care through evidence-based practice, interprofessional collaboration, and system-level problem solving. Recognized for excellence in clinical decision making, mentorship, and quality improvement within acute and rural healthcare environments. Experienced in curriculum delivery, competency evaluation, and professional standards development. Currently serving as Clinical Pharmacist Site Lead at an acute care hospital in Northern Ontario, overseeing clinical service delivery, practice standards, interdisciplinary integration, and continuous quality improvement. Highly motivated, detail-oriented, and committed to upholding professional rigor, patient safety, innovation and compassionate delivery of care.

• Nominee for Sunnybrook Schulich Award of Clinical Excellence, 2009-01-01
• Nominee for University of Toronto Structured Practical Experience Program Teaching Associate Award of Excellence, 2004-01-01
• Recipient of John Iazzetta Award for Exemplary Pharmacist of the Year, 2003-01-01

• Incidence of Nephrotoxicity in Patients Receiving High dose Methotrexate at Sunnybrook Health Sciences Centre: A Retrospective Study, Shen C, Chan I, Peragine C, Vyas A, MASCC Abstract, 2021-03-01
• Voriconazole Prophylaxis in Leukemic Patients: A retrospective single center study, Walker S, Bui V, Elligsen M, Palmay L, Vyas A, Journal of Oncology Pharmacy Practice, 2019-01-01, 24, 6
• Identifying Barriers to Medication Discharge Counselling by Pharmacists, Walker S, Lo J, Compani S, Ko E, Le M, Marchesano R, Natanson R, Pradhan R, Rzyczniak G, Teo V, Vyas A, Can J Hosp Pharm, 2014-01-01, 67, 3, 203-12
• Rituximab improves overall survival in patients treated with CODOXM/IVAC for Burkitt Lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and BL: a single center experience and review of the literature, Pratzer A, Cheung M, Thompson K, Piliotis E, Berinstein N, Imrie K, Pradhan R, Vyas A, Good D, Zhang L, Buckstein R, Blood, 2013-01-01, 122, 5093
• Use of a Whiteboard on a Surgical Oncology Unit as a Communication Tool: The Patient's Perspective, Long A, Glavassevich M, Leung B, Greene S, Samonte R, Henry I, Wheeler V, Vyas A, Ferguson H, Robinson C, Abstract #177. 23rd Annual CANO/ACIO, Halifax, Nova Scotia, 2011-01-01
• Utility or Futility? Use of Chemotherapy in End Stage Cancer Patients Admitted for Symptom Control, Simmons C, Trudeau M, Vyas A, Sue J, Fralick J, Clemons M, Supportive Care in Cancer, 2005-01-01, American Society of Clinical Oncology 41st Annual Meeting, Orlando, FL, 2005-05-01, 18th International Symposium, Toronto, ON, 2006-06-01